TUKWILA, Wash. — Behavioral health pharmacy and telepsychiatry company Genoa, a QoL Healthcare company, has acquired Medication Management Systems, enabling the introduction of its medication therapy management technology offering, Genoa Medication Management Solutions.
The technology acquired from Medication Management systems allows for improved treatment plans by making recommendations related to pharmaceutical care for patients with multiple conditions.
“The combination of our capabilities provides an end-to-end solution that strengthens and expands our comprehensive pharmacy offerings,” Genoa CEO John Figueroa said. “As a company, we are focused on providing interventions that continue to achieve more than 90% medication adherence rates. This acquisition enables us to do that for more people,” he said.
Medication Management Systems currently provides medication management services to more than 30,000 patients through health plans, and Medicare and Medicaid managed care organizations with more than 4 million members 300 Centers for Medicare and Medicaid Services contracts license its platforms.
“We already do a great job of improving the lives of those living with a mental illness,” Genoa chief commercial officer Mark Peterson said. “Many people with complex health conditions also have underlying mental health issues. This enables us to serve a broader population.”
MMS also is participating in a CMS innovations program to offer enhanced MTM services to Medicare beneficiaries. The company was founded in 2006 when it was spun out of the newly formed University of Minnesota Venture Center.
"We are very excited to become part of Genoa," MMS CEO and chairman David McLean said. "Genoa’s national footprint, deep industry relationships and expertise providing comprehensive pharmacy solutions to high-risk populations, combined with our patient-centered comprehensive medication management service and technology platform, position us for success far into the future."